Management Change26 Aug 2026, 07:10 pm
Senores Pharma Appoints Independent Director, Company Secretary
AI Summary
Senores Pharmaceuticals Limited announced board approvals for key appointments and strategic initiatives. Mrs. Shilpa Sharma has been appointed as Company Secretary and Compliance Officer. Mr. Viranchi Arvindbhai Shah joins as Non-Executive Additional Independent Director. The board also authorized key personnel to determine materiality and make disclosures. Additionally, the company approved the Senores Pharmaceuticals Employee Stock Option Scheme 2026 (ESOS 2026) and the incorporation of a Wholly Owned Subsidiary in Mexico to expand international market presence.
Key Highlights
- Appointment of Mr. Viranchi Arvindbhai Shah as Independent Director.
- Mrs. Shilpa Sharma appointed as Company Secretary and Compliance Officer.
- Board approved ESOS 2026, subject to shareholder approval.
- Company to establish a Wholly Owned Subsidiary in Mexico.
- Key personnel authorized for disclosure and materiality determination.
Price Impact
More from SENORES